Cardiology at Shanghai First People's Hospital | CMCS

Expert Heart Disease Care at One of Shanghai's Premier Academic Medical Centers

The Department of Cardiology at Shanghai First People's Hospital — affiliated with Shanghai Jiao Tong University School of Medicine — is one of Shanghai's most distinguished cardiology centers, with a national reputation for excellence in interventional cardiology, heart failure, structural heart disease, cardiac electrophysiology, and the management of complex cardiovascular conditions. With a high-volume interventional program and state-of-the-art hybrid operating theater capability, the department combines outstanding clinical expertise with a world-class research program, offering international patients access to some of China's most eminent cardiologists. China Medical Concierge Shanghai (CMCS) provides seamless end-to-end coordination for international patients throughout their cardiac care journey at Shanghai First People's Hospital.

About the Department

The cardiology department is a national key clinical specialty operating dedicated cardiac care wards, a coronary care unit (CCU), multiple cardiac catheterization laboratories, an electrophysiology laboratory, an echocardiography laboratory, a heart failure clinic, a structural heart disease program, a cardiac rehabilitation program, and works in close collaboration with cardiac surgery, vascular surgery, and critical care through a fully integrated multidisciplinary Heart Team.

Coronary Artery Disease

Stable & Acute Coronary Syndromes

• Stable CAD — Optimal medical therapy; FFR and iFR-guided PCI; drug-eluting stent implantation; CCTA for non-invasive assessment; CABG coordination for complex multivessel disease; SYNTAX score-guided decision-making
• STEMI — 24/7 primary PCI capability; door-to-balloon time optimization; radial access PCI; drug-eluting stent implantation; aspiration thrombectomy; mechanical circulatory support for cardiogenic shock
• NSTEMI & Unstable Angina — Risk stratification (GRACE, TIMI); early invasive strategy; DAPT optimization (ticagrelor, prasugrel); cangrelor for bridging
• Complex PCI — Left main PCI; bifurcation PCI (two-stent techniques: DK crush, culotte); CTO PCI (antegrade and retrograde); calcified lesion PCI with rotational atherectomy and IVL (Shockwave); IVUS and OCT-guided PCI for optimal stent expansion
• Post-ACS Management — Cardiac rehabilitation; PCSK9 inhibitors (evolocumab, alirocumab); inclisiran; icosapentaenoic acid (Vascepa/REDUCE-IT)

Cardiogenic Shock

• Mechanical Circulatory Support — Impella CP and 5.5; VA-ECMO; IABP; multidisciplinary shock team; early revascularization; escalation and de-escalation protocols
• ECMO Program — VA-ECMO for refractory cardiogenic shock; ECMO-supported high-risk PCI; ECMO bridge to recovery and transplantation

Heart Failure

• HFrEF — Quadruple therapy: ARNI (sacubitril/valsartan) + beta-blocker + MRA + SGLT2 inhibitor (dapagliflozin/empagliflozin); ivabradine; hydralazine + nitrates; vericiguat
• HFpEF — SGLT2 inhibitors (empagliflozin — EMPEROR-Preserved; dapagliflozin — DELIVER); spironolactone; finerenone; blood pressure and rate control
• HFmrEF — SGLT2 inhibitors; ARNI; beta-blockers; MRA
• Advanced Heart Failure — Inotropic support (dobutamine, milrinone, levosimendan); Impella; VA-ECMO; CRT; ICD; LVAD evaluation; cardiac transplantation evaluation and coordination
• Cardiac Amyloidosis — Tafamidis (Vyndamax/Vyndaqel) for ATTR-CM; acoramidis (Attruby); eplontersen and patisiran for hereditary ATTR; PYP scan for ATTR diagnosis; daratumumab for AL amyloidosis; one of Shanghai's most experienced cardiac amyloidosis programs
• Hypertrophic Cardiomyopathy (HCM) — Beta-blockers; mavacamten (Camzyos); aficamten; alcohol septal ablation; surgical myectomy coordination; ICD for SCD prevention; genetic testing (MYH7, MYBPC3)
• Dilated Cardiomyopathy — Guideline-directed medical therapy; genetic testing (TTN, LMNA, SCN5A); ICD for LMNA-DCM; cardiac transplantation evaluation

Structural Heart Disease

• TAVR (Transcatheter Aortic Valve Replacement) — For severe aortic stenosis in high, intermediate, and low surgical risk; transfemoral approach; valve-in-valve TAVR; one of Shanghai's experienced TAVR programs; CT-guided planning; 30-day and 1-year outcomes benchmarked against international registries
• MitraClip / TEER — For primary and secondary mitral regurgitation; COAPT criteria for functional MR; 3D TEE guidance
• Tricuspid Interventions — TriClip for severe tricuspid regurgitation; EVOQUE transcatheter tricuspid valve replacement
• Left Atrial Appendage Closure (LAAC) — Watchman FLX and Amulet for AF patients with contraindication to anticoagulation; ICE-guided implantation
• PFO Closure — For cryptogenic stroke; Amplatzer PFO Occluder; Gore Cardioform
• ASD & VSD Closure — Transcatheter closure; Amplatzer devices; 3D TEE guidance
• PMBV — Percutaneous mitral balloon valvuloplasty for rheumatic mitral stenosis

Cardiac Electrophysiology

• Atrial Fibrillation (AF) — Rate and rhythm control; pulmonary vein isolation (PVI) by radiofrequency ablation; cryoablation (Arctic Front Advance Pro); pulsed field ablation (PFA — Farapulse, Volt); one of Shanghai's most experienced AF ablation programs
• Atrial Flutter — CTI ablation; cardioversion
• SVT Ablation — AVNRT; AVRT; WPW syndrome; atrial tachycardia; 3D mapping (CARTO, EnSite Precision)
• Ventricular Tachycardia (VT) — Catheter ablation for scar-related VT; idiopathic VT; epicardial ablation; ICD programming optimization; VT storm management
• Pacemaker & Device Therapy — Permanent pacemaker; His bundle pacing (HBP); left bundle branch area pacing (LBBAP) for physiological pacing; leadless pacemaker (Micra AV); CRT-P and CRT-D; S-ICD; WCD (LifeVest)
• Inherited Arrhythmia Syndromes — Long QT syndrome; Brugada syndrome; CPVT; ARVC; genetic testing and family screening; ICD for high-risk patients

Hypertension & Preventive Cardiology

• Resistant Hypertension — Spironolactone; eplerenone; finerenone; renal denervation (Symplicity Spyral); amiloride; doxazosin; secondary hypertension workup
• Lipid Management — High-intensity statins; ezetimibe; PCSK9 inhibitors (evolocumab, alirocumab); inclisiran (siRNA); bempedoic acid; omega-3 fatty acids; LDL apheresis for familial hypercholesterolemia
• Cardiac Rehabilitation — Phase I-III cardiac rehabilitation; exercise prescription; risk factor modification; psychological support; return to work

Cardiac Imaging

• Echocardiography — TTE and TEE; 3D echocardiography; stress echo; ICE for procedural guidance; strain imaging (GLS); diastolic function assessment
• Cardiac CT — CCTA; TAVR planning CT; calcium scoring; structural heart disease planning; coronary CTA-derived FFR (CT-FFR)
• Cardiac MRI — Myocardial viability; cardiomyopathy characterization; cardiac amyloidosis (T1 mapping, ECV); myocarditis; ARVC; stress perfusion CMR
• Nuclear Cardiology — Myocardial perfusion imaging (SPECT, PET); PYP scan for ATTR amyloidosis; FDG-PET for cardiac sarcoidosis and device infection

Why International Patients Choose Shanghai First People's Hospital Cardiology

• Pulsed Field Ablation (PFA) — Farapulse and Volt PFA systems for AF ablation; superior pulmonary vein isolation with reduced collateral damage
• Cardiac Amyloidosis Program — One of Shanghai's most experienced ATTR-CM programs; tafamidis, acoramidis, eplontersen; PYP scan diagnosis
• Mavacamten for HCM — Cardiac myosin inhibitor for obstructive HCM; EXPLORER-HCM evidence
• LBBAP Physiological Pacing — Left bundle branch area pacing for CRT-like resynchronization without coronary sinus lead
• ECMO Program — VA-ECMO for refractory cardiogenic shock and high-risk PCI support
• Cost-Effectiveness — World-class cardiac care at significantly lower cost than equivalent treatment in Western countries

The CMCS Patient Journey

1. Initial Inquiry — Share your cardiac diagnosis, ECG, echocardiography reports, cardiac catheterization data, and current medications with CMCS.
2. Medical Record Preparation — We translate and organize your records for specialist pre-consultation review.
3. Specialist Matching — We identify the most appropriate cardiologist based on your condition — interventional cardiology, structural heart disease, heart failure, electrophysiology, or preventive cardiology.
4. MDT Submission — Where appropriate, we facilitate pre-arrival case review by the multidisciplinary Heart Team.
5. Priority Scheduling — We secure a consultation with minimal waiting time.
6. Travel & Logistics — Assistance with visa invitation letters, accommodation near Shanghai First People's Hospital, and Shanghai airport transfers.
7. Procedural Coordination — Full coordination of cardiac catheterization, TAVR, ablation, or device implantation procedures.
8. Post-Procedure Follow-Up — Procedure report translation, medication guidance, cardiac rehabilitation coordination, and remote follow-up after you return home.

Book a Consultation

If you have coronary artery disease, heart failure, structural heart disease, an arrhythmia, or a complex cardiovascular condition — CMCS can arrange a specialist consultation with Shanghai First People's Hospital's cardiology team.

📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com